Routine Form 3 filing for a new officer. No immediate trading signal; monitor future Form 4 filings for any open-market purchases or sales by the insider.
How the stock moved after the report
⚠ Clustered NEUTRAL VIEWSTOCK BELOW ENTRY AT T+1- T+0 · Oct 29 $14.89entry
- T+1 · 6d ago −12.42%α −11.95% · $13.04
- T+5 · due 11h ago Pending
- T+5 · todayOpen
- T+20 · in 22d Pending
- T+60 · in 3mo Pending
Price Chart
How similar events traded
Executive Summary
Lisa Johnson-Pratt, Chief Commercial Officer of Aspen Neuroscience, filed a Form 3 initial statement of beneficial ownership, disclosing stock option grants totaling 146,729 shares at exercise prices between $5.74 and $8.70. The filing is a routine insider onboarding requirement with no material financial impact.
Key Facts
- Lisa Johnson-Pratt appointed Chief Commercial Officer of Aspen Neuroscience, Inc.
- Form 3 filed on 2026-10-29 disclosing initial beneficial ownership.
- Disclosed three stock option grants: 40,477 shares at $7.42 (granted 2024-03-28), 40,477 shares at $8.70 (granted 2024-12-11), and 65,775 shares at $5.74 (granted 2025-11-26).
- Total option shares: 146,729, all unexercised and subject to vesting schedules tied to continued service.
Financial Impact
No financial impact; filing is a routine insider ownership disclosure with no transaction or corporate event.
Risk Factors
- No material risks identified from this filing.
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 3 Filing (Primary) | 0001193125-26-438915 |
| Document: 0001193125-26-438915-index-headers.html | 0001193125-26-438915 |
| Document: 0001193125-26-438915-index.html | 0001193125-26-438915 |
| Document: 0001193125-26-438915.txt | 0001193125-26-438915 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Nov 3, 2026 2d ago | SC 13G | $12.29 $12.76 | ▲ +3.82% | ▲ +2.17% | $11.76 (−4.31%) |
Nov 2, 2026 2d ago | Insider Cluster | $12.29 $12.76 | ▲ +3.82% | ▲ +2.17% | $11.76 (−4.31%) |
Nov 2, 2026 2d ago | Insider Cluster | $12.29 $12.76 | ▲ +3.82% | ▲ +2.17% | $11.76 (−4.31%) |
Nov 2, 2026 3d ago | 8-K | $12.29 $12.76 | ▲ +3.82% | ▲ +2.17% | $11.76 (−4.31%) |
Oct 30, 2026 6d ago | 424B4 | $13.04 $12.29 | ▼ −5.75% | ▼ −6.05% | $11.76 (−9.82%) |
Oct 30, 2026 6d ago | EFFECT | $14.89 $13.04 | ▼ −12.42% | ▼ −11.95% | $11.76 (−21.02%) |
Oct 29, 2026 6d ago | Press Release | $14.89 $13.04 | ▼ −12.42% | ▼ −11.95% | $11.76 (−21.02%) |
Oct 29, 2026 6d ago | 3 | $14.89 $13.04 | ▼ −12.42% | ▼ −11.95% | $11.76 (−21.02%) |
Oct 29, 2026 6d ago | 3 | $14.89 $13.04 | ▼ −12.42% | ▼ −11.95% | $11.76 (−21.02%) |
Oct 29, 2026 6d ago | 3 | $14.89 $13.04 | ▼ −12.42% | ▼ −11.95% | $11.76 (−21.02%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers